Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
University of California San Diego School of Medicine, USA
Список исп. литературыСкрыть список 1. Stahl SM. Stahl’s Essential Psychopharmacology. 4th ed. NY: Cambridge University Press, 2013. 2. De Bodinat C, Guardiola-Lemaitre B, Mocaer E. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Dis 2010; 9 (8): 928–42. 3. Zajecka J, Schatzberg A, Stahl S et al. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2010; 30 (2): 135–44. 4. Stahl SM, Fava M, Trivedi M et al. Agomelatine in the treatment of major depressive disorder: an 8 week, multicenter, randomized, placebo-controlled trial. J Clin Psychiat 2010; 71 (5): 616–26. 5. Chenu F, El Mansari M, Blier P. Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine and serotonin systems in the rat brain. Neuropsychopharmacol 2013; 38 (2): 275–84. 6. Molteni R, Calabrese F, Pisoni S et al. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine. World J Biol Psychiat 2010; 11 (2): 148–53. 7. Tardito D, Milanese M, Bonifacino T et al. Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C-receptordependent pathways. BMC Neurosci 2010; 11: 68. 8. Nutt D, Demyttenaere K, Janka Z et al. The other face of depression, reduced positive affect: the role of catecholamine’s in causation and cure. J Psychopharmacol 2007; 21 (5): 461–71. 9. Martinotti G, Sepede G, Gambi F et al. Agomelatine vs. venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol 2012; 32 (4): 487–91. 10. Corruble E, de Bodinat C, Belaidi C, Goodwin GM. Agomelatine Study Group. Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-week randomized, controlled, double-blind trial. Int J Neuropsychopharmacol 2013; 16 (10): 2219–34. 11. Lemoine P, Guilleminault C, Alvarez E. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiat 2007; 68 (11): 1723–32. 12. Quera-Salva MA, Hajak G, Philip P et al. Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients. Int Clin Psychopharmacol 2011; 26 (5): 252–62. 13. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008; 28 (3): 329–33.